INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings

Most active filers · 30d

  1. 01Kurtz George0B / 204S204 trades$51.20M
  2. 02SPSaba Capital Management, L.P.68B / 23S · 14 late91 trades$30.01M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  6. 06SJSheena Jonathan0B / 43S43 trades$3.14M
  7. 07CFCheng Chi Fung0B / 42S42 trades$15.33M
  8. 08SLSpeiser Michael L0B / 35S35 trades$14.00M
  9. 09RARothblatt Martine A0B / 33S33 trades$5.50M
  10. 10RJRubinstein Julie0B / 33S33 trades$5.33M
Data sources
SEC Form 451m ago
House PTR51m ago
SEC 13F50m ago
Robinhood Chain50m ago

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
  4. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  5. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  6. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  7. SELLADUSAddus HomeCare CorpNov 6 – Nov 96 insiders$16.28M
  8. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K

Form 4 transactions

67,706 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
17
EF
Esaka FumihideDirector, Chief Executive Officer
AMBQAmbiq Micro, Inc.
Open-market sale · 10b5-1 plan
SELL$318K
5,501 sh
Aug 31, 2026Sep 2, 2026
Page 413 of 1693
← PrevNext →
traded Aug 31, 2026
+2d
SEC Form 4

Evidence

17
CA
Chatterjee AnkurChief Integration Officer
QMLSQumulusAI, Inc.
Grant or award
A—
69.6K sh
Sep 1, 2026Sep 2, 2026
traded Sep 1, 2026
+1dSEC Form 4

Evidence

17
AK
Akgonul Rifat KerimChief Product Officer
PEGAPEGASYSTEMS INC
Option exercise
M—
1,176 sh
Sep 1, 2026Sep 2, 2026
traded Sep 1, 2026
+1dSEC Form 4

Evidence

17
EW
Eager William WDirector, Chief Executive Officer
MBGLMobility Global Inc.
Grant or award
A—
126.1K sh
Sep 1, 2026Sep 2, 2026
traded Sep 1, 2026
+1dSEC Form 4

Evidence

16
SE
Schubach Sarah ElizabethChief Accounting Officer
DBXDROPBOX, INC.
Open-market sale · 10b5-1 plan
SELL$58K
1,631 sh
Aug 31, 2026Sep 2, 2026
traded Aug 31, 2026
+2dSEC Form 4

Evidence

16
LX
Lin XichenCHIEF SCIENTIFIC OFFICER
GPCRStructure Therapeutics Inc.
Open-market sale · 10b5-1 plan
SELL$214K
4,539 sh
Sep 1, 2026Sep 2, 2026
traded Sep 1, 2026
+1dSEC Form 4

Evidence

16
ST
Skeik TarikChief Operating Officer
NEXTNextDecade Corp
Tax withholding
F$136K
18.0K sh
Aug 31, 2026Sep 2, 2026
traded Aug 31, 2026
+2dSEC Form 4

Evidence

16
OE
Owen Katey EinterzDirector
ADPTAdaptive Biotechnologies Corp
Gift
G—
12.5K sh
Aug 31, 2026Sep 2, 2026
traded Aug 31, 2026
+2dSEC Form 4

Evidence

16
SJ
Swain JunkoSVP, Chief Accounting Officer
WKWORKIVA INC
Tax withholding
F$165K
2,151 sh
Sep 1, 2026Sep 2, 2026
traded Sep 1, 2026
+1dSEC Form 4

Evidence

15
NP
Norris Michael PaulGROUP PRESIDENT
ASTEASTEC INDUSTRIES INC
Grant or award
A—
23 sh
Aug 28, 2026Sep 2, 2026
traded Aug 28, 2026
+5dSEC Form 4

Evidence

15
PG
Putney Robert GeraldVP, Chief Accounting Officer
ASTEASTEC INDUSTRIES INC
Grant or award
A—
3 sh
Aug 28, 2026Sep 2, 2026
traded Aug 28, 2026
+5dSEC Form 4

Evidence

15
KI
Knoll Linda I.Director
ASTEASTEC INDUSTRIES INC
Grant or award
A—
7 sh
Aug 28, 2026Sep 2, 2026
traded Aug 28, 2026
+5dSEC Form 4

Evidence

15
HE
Henderson Mary ElizabethSVP, Technical Operations
JAZZJazz Pharmaceuticals plc
Tax withholding
F$501K
2,076 sh
Aug 31, 2026Sep 2, 2026
traded Aug 31, 2026
+2dSEC Form 4

Evidence

15
WM
Winford James Murphy JrDirector
ASTEASTEC INDUSTRIES INC
Grant or award
A—
7 sh
Aug 28, 2026Sep 2, 2026
traded Aug 28, 2026
+5dSEC Form 4

Evidence

15
LL
Linnenbringer Jeanne L.Chief Operations Officer
CNOCNO Financial Group, Inc.
Open-market sale · 10b5-1 plan
SELL$275K
5,010 sh
Aug 31, 2026Sep 2, 2026
traded Aug 31, 2026
+2dSEC Form 4

Evidence

15
YJ
York JakobCHIEF FINANCIAL OFFICER
FTLFFITLIFE BRANDS, INC.
Grant or award
A—
4,000 sh
Aug 28, 2026Sep 2, 2026
traded Aug 28, 2026
+5dSEC Form 4

Evidence

15
HJ
Hartley Chad JeffreyGroup President
ASTEASTEC INDUSTRIES INC
Grant or award
A—
38 sh
Aug 28, 2026Sep 2, 2026
traded Aug 28, 2026
+5dSEC Form 4

Evidence

14
SB
Sousa Mauad BrunoDirector
AUGOAura Minerals Inc.
Open-market sale
SELL$26.74
1 sh
Aug 31, 2026Sep 2, 2026
traded Aug 31, 2026
+2dSEC Form 4

Evidence

14
EF
Esaka FumihideDirector, Chief Executive Officer
AMBQAmbiq Micro, Inc.
Open-market sale · 10b5-1 plan
SELL$544K
9,575 sh
Sep 2, 2026Sep 2, 2026
traded Sep 2, 2026
+0dSEC Form 4

Evidence

14
EF
Esaka FumihideDirector, Chief Executive Officer
AMBQAmbiq Micro, Inc.
Open-market sale · 10b5-1 plan
SELL$123K
2,100 sh
Aug 31, 2026Sep 2, 2026
traded Aug 31, 2026
+2dSEC Form 4

Evidence

13
QB
Quebedeaux Amanda B.Chief Operations Officer
CLSTCatalyst Bancorp, Inc.
Tax withholding
F$9,849
553 sh
Sep 1, 2026Sep 2, 2026
traded Sep 1, 2026
+1dSEC Form 4

Evidence

13
GJ
Gahan Patrick JosephDirector
QMLSQumulusAI, Inc.
Grant or award
A—
60.7K sh
Sep 1, 2026Sep 2, 2026
traded Sep 1, 2026
+1dSEC Form 4

Evidence

13
PE
Peschard Mijares Guillermo EduardoEVP
BCOBRINKS CO
Grant or award
A$5,689
52 sh
Aug 31, 2026Sep 2, 2026
traded Aug 31, 2026
+2dSEC Form 4

Evidence

13
LX
Lin XichenCHIEF SCIENTIFIC OFFICER
GPCRStructure Therapeutics Inc.
Open-market sale · 10b5-1 plan
SELL$4,783
100 sh
Sep 1, 2026Sep 2, 2026
traded Sep 1, 2026
+1dSEC Form 4

Evidence

13
GJ
Gahan Patrick JosephDirector
QMLSQumulusAI, Inc.
Grant or award
A—
48.6K sh
Sep 1, 2026Sep 2, 2026
traded Sep 1, 2026
+1dSEC Form 4

Evidence

13
VS
Vatnick SilvinaDirector
CIBGrupo Cibest S.A.
Disposition to issuer
D$10K
1,060 sh
Aug 31, 2026Sep 2, 2026
traded Aug 31, 2026
+2dSEC Form 4

Evidence

13
LL
Linnenbringer Jeanne L.Chief Operations Officer
CNOCNO Financial Group, Inc.
Open-market sale · 10b5-1 plan
SELL$222K
4,060 sh
Sep 1, 2026Sep 2, 2026
traded Sep 1, 2026
+1dSEC Form 4

Evidence

13
DV
de Gyarfas VeraGeneral Counsel
NEXTNextDecade Corp
Grant or award
A—
132.6K sh
Aug 31, 2026Sep 2, 2026
traded Aug 31, 2026
+2dSEC Form 4

Evidence

13
GR
Gertz Stephen RalphChief Growth Officer
QMLSQumulusAI, Inc.
Grant or award
A—
19.2K sh
Sep 1, 2026Sep 2, 2026
traded Sep 1, 2026
+1dSEC Form 4

Evidence

13
SP
Schwartz Barry PaulDirector
QMLSQumulusAI, Inc.
Grant or award
A—
9,583 sh
Sep 1, 2026Sep 2, 2026
traded Sep 1, 2026
+1dSEC Form 4

Evidence

13
LL
Linnenbringer Jeanne L.Chief Operations Officer
CNOCNO Financial Group, Inc.
Open-market sale · 10b5-1 plan
SELL$216K
3,919 sh
Sep 2, 2026Sep 2, 2026
traded Sep 2, 2026
+0dSEC Form 4

Evidence

13
CW
Cook Kristen WilliamsEVP & CLO
BCOBRINKS CO
Grant or award
A$4,333
40 sh
Aug 31, 2026Sep 2, 2026
traded Aug 31, 2026
+2dSEC Form 4

Evidence

13
HR
Hasani RamiEVP, Chief Financial Officer
UWMCUWM Holdings Corp
Option exercise
M$3,425
2,500 sh
Sep 1, 2026Sep 2, 2026
traded Sep 1, 2026
+1dSEC Form 4

Evidence

13
DF
DeBruine Thomas FChief Operating Officer
BRCBRADY CORP
Grant or award
A—
3,765 sh
Sep 1, 2026Sep 2, 2026
traded Sep 1, 2026
+1dSEC Form 4

Evidence

13
MW
McClintock WilliamDirector
IDAIT Stamp Inc
Grant or award
A—
52 sh
Aug 31, 2026Sep 2, 2026
traded Aug 31, 2026
+2dSEC Form 4

Evidence

13
SP
Schwartz Barry PaulDirector
QMLSQumulusAI, Inc.
Grant or award
A—
9,583 sh
Sep 1, 2026Sep 2, 2026
traded Sep 1, 2026
+1dSEC Form 4

Evidence

13
SK
Sterrett KelliEVP, General Counsel & Secrtry
VYXNCR Voyix Corp
Tax withholding
F$36K
4,152 sh
Sep 1, 2026Sep 2, 2026
traded Sep 1, 2026
+1dSEC Form 4

Evidence

13
PS
Peek Mark SDirector
MBGLMobility Global Inc.
Grant or award
A—
11.1K sh
Sep 1, 2026Sep 2, 2026
traded Sep 1, 2026
+1dSEC Form 4

Evidence

13
BL
Boylston LukeChief Accounting Officer
NEXTNextDecade Corp
Grant or award
A—
23.9K sh
Aug 31, 2026Sep 2, 2026
traded Aug 31, 2026
+2dSEC Form 4

Evidence

12
LX
Lin XichenCHIEF SCIENTIFIC OFFICER
GPCRStructure Therapeutics Inc.
Open-market sale · 10b5-1 plan
SELL$60K
1,300 sh
Sep 1, 2026Sep 2, 2026
traded Sep 1, 2026
+1dSEC Form 4

Evidence